跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOROMBY HP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NOROMBY HP
Authorized
STANDARD
NOROMBY HP
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bb375df3eb1bb9ce
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
bb375df3eb1bb9ce
Drug Approval Canada Name
NOROMBY HP
Product Name
NOROMBY HP
Status
Marketed
Status Date
2021-06-25
Original Market Date
2021-06-25
Din
02506513
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intravenous
Schedule
Prescription
Ahfs
20:12.04.16
Atc Original
B01AB05 ENOXAPARIN
Atc Name
b 01 ab 05
Aig Number
0131860002
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
ENOXAPARIN SODIUM
150 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bb375df3eb1bb9ce
Type
Standard
Back to Health Canada Approvals